Israeli drug repairs nerve tissue in MS patients

An independent 12-month MRI study of Teva’s Copaxone multiple sclerosis treatment has reported significant regeneration of brain tissue of MS sufferers and proves Copaxone’s ability to repair the brain lesions responsible for MS.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.